Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 2.07% | $20.23M | $509.42B | 98.71% | 81 Outperform | |
| Novartis | 1.25% | $12.26M | $306.84B | 40.98% | 80 Outperform | |
| Roche Holding AG | 1.21% | $11.82M | CHF265.95B | 26.59% | 73 Outperform | |
| AstraZeneca | 0.98% | $9.60M | $300.78B | 21.96% | 80 Outperform | |
| Royal Bank Of Canada | 0.97% | $9.46M | $228.02B | 44.65% | 75 Outperform | |
| Rolls-Royce Holdings | 0.71% | $6.98M | £104.29B | 77.89% | 71 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.68% | $6.70M | €247.40B | -20.90% | 78 Outperform | |
| Toyota Motor | 0.67% | $6.58M | ¥44.22T | 19.51% | 80 Outperform | |
| Unilever | 0.60% | $5.91M | $143.90B | -2.16% | 73 Outperform | |
| ― | 0.56% | $5.47M | ― | ― | ― |